Saija J. Ahonen
555 University Avenue
Toronto, ON M5G1X8, Canada
Toronto, ON M5G1X8, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Correction to: Nationwide genetic testing towards eliminating Lafora disease from Miniature Wirehaired Dachshunds in the United Kingdom.
Journal: Canine medicine and genetics
Published: December 28, 2021
Glycogen synthase downregulation rescues the amylopectinosis of murine RBCK1 deficiency.
Journal: Brain : a journal of neurology
Published: October 29, 2021
Canine Lafora Disease: An Unstable Repeat Expansion Disorder.
Journal: Life (Basel, Switzerland)
Published: June 17, 2021
Gys1 antisense therapy rescues neuropathological bases of murine Lafora disease.
Journal: Brain : a journal of neurology
Published: January 29, 2021
An inducible glycogen synthase-1 knockout halts but does not reverse Lafora disease progression in mice.
Journal: The Journal of biological chemistry
Published: August 26, 2020
SUCLA2 Arg407Trp mutation can cause a nonprogressive movement disorder - deafness syndrome.
Journal: Annals of clinical and translational neurology
Published: July 28, 2020
Sensitive quantification of α-glucans in mouse tissues, cell cultures, and human cerebrospinal fluid.
Journal: The Journal of biological chemistry
Published: June 30, 2020
Lafora disease - from pathogenesis to treatment strategies.
Journal: Nature reviews. Neurology
Published: August 26, 2018
Nationwide genetic testing towards eliminating Lafora disease from Miniature Wirehaired Dachshunds in the United Kingdom.
Journal: Canine genetics and epidemiology
Published: December 15, 2017
Ocular phenotype and electroretinogram abnormalities in Lafora disease: A "window to the brain".
Journal: Neurology
Published: November 28, 2017
Update on Pharmacological Treatment of Progressive Myoclonus Epilepsies.
Journal: Current pharmaceutical design
Published: June 20, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026